Kuros Biosciences AG (CSBTF)

Market Cap	1.25B +39.7%
Revenue (ttm)	129.96M +129.8%
Net Income	-7.63M
EPS	-0.17
Shares Out	n/a
PE Ratio	n/a
Forward PE	85.83
Dividend	n/a
Ex-Dividend Date	n/a

Volume	250
Average Volume	651
Open	32.00
Previous Close	31.91
Day's Range	32.00 - 32.00
52-Week Range	19.44 - 42.81
Beta	0.62
RSI	41.61
Earnings Date	Mar 10, 2026

About Kuros Biosciences AG

Kuros Biosciences AG engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally. It operates through two segments, Medical Devices and Legacy Portfolio. The company offers MagnetOs Granules, an original advanced bone graft based on the submicron needle-shaped NeedleGrip surface technology; MagnetOs Putty, a mold uses to fill bony voids for intervertebral disc space or posterolateral spine; and Attrax, a biphasic calcium phosphate bon...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2016
• Employees: 158
• Stock Exchange: OTCMKTS
• Ticker Symbol: CSBTF

Financial Performance

In 2024, Kuros Biosciences AG's revenue was 75.56 million, an increase of 125.11% compared to the previous year's 33.56 million. Losses were -4.29 million, -68.75% less than in 2023.

Financial numbers in CHF